Background:
Studies in patients with acute coronary syndrome (ACS) undergoing invasive management showed conflicting conclusions regarding the effect of access site on outcomes.
Purpose:
To summarize evidence from recent, high-quality trials that compared clinical outcomes occurring with radial versus femoral access in invasively managed adults with ACS.
Data Sources:
English-language publications in MEDLINE, EMBASE, and Cochrane databases between January 1990 and August 2015.
Study Selection:
Randomized trials of radial versus femoral access in invasively managed patients with ACS.
Data Extraction:
Two investigators independently extracted the study data and rated the risk of bias.
Data Synthesis:
Of 17 identified randomized trials, 4 were high-quality multicenter trials that involved a total of 17 133 patients. Pooled data from the 4 trials showed that radial access reduced death (relative risk [RR], 0.73 [95% CI, 0.59 to 0.90]; P = 0.003), major adverse cardiovascular events (RR, 0.86 [CI, 0.75 to 0.98]; P = 0.025), and major bleeding (RR, 0.57 [CI, 0.37 to 0.88]; P = 0.011). Radial procedures lasted slightly longer (standardized mean difference, 0.11 minutes) and had higher risk for access-site crossover (6.3% vs. 1.7%) than did femoral procedures.
Limitation:
Heterogeneity in outcomes definitions and potential treatment modifiers across studies, including operator experience in radial procedures and concurrent anticoagulant regimens.
Conclusion:
Compared with femoral access, radial access reduces mortality, major adverse cardiovascular events, and major bleeding in patients with ACS undergoing invasive management.
Primary Funding Source:
None. (PROSPERO registration number: CRD42015022031)
References
- 1.
Franchi F ,Angiolillo DJ . Novel antiplatelet agents in acute coronary syndrome. Nat Rev Cardiol. 2015;12:30-47. [PMID:25286881 ] CrossrefMedlineGoogle Scholar - 2.
Stone GW ,Witzenbichler B ,Guagliumi G ,Peruga JZ ,Brodie BR ,Dudek D ,et al ;HORIZONS-AMI Trial Investigators . Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218-30. [PMID:18499566 ] CrossrefMedlineGoogle Scholar - 3.
Doyle BJ ,Rihal CS ,Gastineau DA ,Holmes DR . Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53:2019-27. [PMID:19477350 ] CrossrefMedlineGoogle Scholar - 4.
Ndrepepa G ,Neumann FJ ,Richardt G ,Schulz S ,Tölg R ,Stoyanov KM ,et al . Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013;6:354-61. [PMID:23881814 ] CrossrefMedlineGoogle Scholar - 5.
Singh M . Bleeding avoidance strategies during percutaneous coronary interventions. J Am Coll Cardiol. 2015;65:2225-38. [PMID:25998668 ] CrossrefMedlineGoogle Scholar - 6.
Rao SV ,Cohen MG ,Kandzari DE ,Bertrand OF ,Gilchrist IC . The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol. 2010;55:2187-95. [PMID:20466199 ] CrossrefMedlineGoogle Scholar - 7.
Feldman DN ,Swaminathan RV ,Kaltenbach LA ,Baklanov DV ,Kim LK ,Wong SC ,et al . Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012). Circulation. 2013;127:2295-306. [PMID:23753843 ] CrossrefMedlineGoogle Scholar - 8.
Jolly SS ,Amlani S ,Hamon M ,Yusuf S ,Mehta SR . Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132-40. [PMID:19081409 ] CrossrefMedlineGoogle Scholar - 9.
Mann T ,Cubeddu G ,Bowen J ,Schneider JE ,Arrowood M ,Newman WN ,et al . Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol. 1998;32:572-6. [PMID:9741495 ] CrossrefMedlineGoogle Scholar - 10.
Saito S ,Tanaka S ,Hiroe Y ,Miyashita Y ,Takahashi S ,Tanaka K ,et al . Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv. 2003;59:26-33. [PMID:12720237 ] MedlineGoogle Scholar - 11.
Cantor WJ ,Puley G ,Natarajan MK ,Dzavik V ,Madan M ,Fry A ,et al . Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction—the RADIAL-AMI pilot randomized trial. Am Heart J. 2005;150:543-9. [PMID:16169338 ] CrossrefMedlineGoogle Scholar - 12.
Brasselet C ,Tassan S ,Nazeyrollas P ,Hamon M ,Metz D . Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart. 2007;93:1556-61. [PMID:17639099 ] CrossrefMedlineGoogle Scholar - 13.
Li WM ,Li Y ,Zhao JY ,Duan YN ,Sheng L ,Yang BF ,et al . Safety and feasibility of emergent percutaneous coronary intervention with the transradial access in patients with acute myocardial infarction. Chin Med J (Engl). 2007;120:598-600. [PMID:17442210 ] CrossrefMedlineGoogle Scholar - 14.
Chodór P ,Krupa H ,Kurek T ,Sokal A ,Swierad M ,Was T ,et al . RADIal versus femoral approach for percutaneous coronary interventions in patients with Acute Myocardial Infarction (RADIAMI): A prospective, randomized, single-center clinical trial. Cardiol J. 2009;16:332-40. [PMID:19653176 ] MedlineGoogle Scholar - 15.
Chodór P ,Kurek T ,Kowalczuk A ,Swierad M ,Was T ,Honisz G ,et al . Radial vs femoral approach with StarClose clip placement for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. RADIAMI II: a prospective, randomised, single centre trial. Kardiol Pol. 2011;69:763-71. [PMID:21850615 ] MedlineGoogle Scholar - 16.
Jolly SS ,Yusuf S ,Cairns J ,Niemelä K ,Xavier D ,Widimsky P ,et al ;RIVAL trial group . Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409-20. [PMID:21470671 ] CrossrefMedlineGoogle Scholar - 17.
Romagnoli E ,Biondi-Zoccai G ,Sciahbasi A ,Politi L ,Rigattieri S ,Pendenza G ,et al . Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481-9. [PMID:22858390 ] CrossrefMedlineGoogle Scholar - 18.
Bernat I ,Horak D ,Stasek J ,Mates M ,Pesek J ,Ostadal P ,et al . ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63:964-72. [PMID:24211309 ] CrossrefMedlineGoogle Scholar - 19.
Valgimigli M ,Gagnor A ,Calabró P ,Frigoli E ,Leonardi S ,Zaro T ,et al ;MATRIX Investigators . Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465-76. [PMID:25791214 ] CrossrefMedlineGoogle Scholar - 20.
Joyal D ,Bertrand OF ,Rinfret S ,Shimony A ,Eisenberg MJ . Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol. 2012;109:813-8. [PMID:22196787 ] CrossrefMedlineGoogle Scholar - 21.
Karrowni W ,Vyas A ,Giacomino B ,Schweizer M ,Blevins A ,Girotra S ,et al . Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013;6:814-23. [PMID:23968700 ] CrossrefMedlineGoogle Scholar - 22.
De Luca G ,Schaffer A ,Wirianta J ,Suryapranata H . Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. Int J Cardiol. 2013;168:2070-81. [PMID:23490083 ] CrossrefMedlineGoogle Scholar - 23.
Dechartres A ,Trinquart L ,Boutron I ,Ravaud P . Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ. 2013;346:f2304. [PMID:23616031 ] CrossrefMedlineGoogle Scholar - 24.
Egger M ,Juni P ,Bartlett C ,Holenstein F ,Sterne J . How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess. 2003;7:1-76. [PMID:12583822 ] CrossrefMedlineGoogle Scholar - 25.
Moher D ,Liberati A ,Tetzlaff J ,Altman DG ;PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. [PMID:19622551 ] CrossrefMedlineGoogle Scholar - 26.
Higgins J ,Green S . Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: Wiley-Blackwell; 2008. Google Scholar - 27.
DerSimonian R ,Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. [PMID:3802833 ] CrossrefMedlineGoogle Scholar - 28.
Biggerstaff BJ ,Tweedie RL . Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med. 1997;16:753-68. [PMID:9131763 ] CrossrefMedlineGoogle Scholar - 29.
Cornell JE ,Mulrow CD ,Localio R ,Stack CB ,Meibohm AR ,Guallar E ,et al . Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med. 2014;160:267-70. [PMID:24727843 ] LinkGoogle Scholar - 30.
Higgins JP ,Thompson SG ,Deeks JJ ,Altman DG . Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. [PMID:12958120 ] CrossrefMedlineGoogle Scholar - 31.
Vazquez-Rodriguez JM ,Calvino-Santos RA ,Baz-Alonso JA ,Trillo-Nouche R ,Salgado-Fernandez J ,Sanmartin-Fernandez M ,et al . Radial vs. femoral arterial access in emergent coronary interventions for acute myocardial infarction with ST segment elevation. J Am Coll Cardiol. 2007;499 Suppl 2 12B. Google Scholar - 32.
Yan ZX ,Zhou YJ ,Zhao YX ,Liu YY ,Shi DM ,Guo YH ,et al . Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction. Chin Med J (Engl). 2008;121:782-6. [PMID:18701040 ] CrossrefMedlineGoogle Scholar - 33.
Gan L ,Li Q ,Liu R ,Zhao Y ,Qiu J ,Liao Y . Effectiveness and feasibility of transradial approaches for primary percutaneous coronary intervention in patients with acute myocardial infarction. J Nanjing Med Univ. 2009;23:270-4. CrossrefGoogle Scholar - 34.
Hou L ,Wei YD ,Li WM ,Xu YW . Comparative study on transradial versus transfemoral approach for primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction. Saudi Med J. 2010;31:158-62. [PMID:20174731 ] MedlineGoogle Scholar - 35.
Wang YB ,Fu XH ,Wang XC ,Gu XS ,Zhao YJ ,Hao GZ ,et al . Randomized comparison of radial versus femoral approach for patients with STEMI undergoing early PCI following intravenous thrombolysis. J Invasive Cardiol. 2012;24:412-6. [PMID:22865313 ] MedlineGoogle Scholar - 36.
Koltowski L ,Filipiak KJ ,Kochman J ,Pietrasik A ,Rdzanek A ,Huczek Z ,et al . Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral—a prospective, randomised clinical trial (OCEAN RACE). Kardiol Pol. 2014;72:604-11. [PMID:24671918 ] CrossrefMedlineGoogle Scholar - 37.
Mehta SR ,Jolly SS ,Cairns J ,Niemela K ,Rao SV ,Cheema AN ,et al ;RIVAL Investigators . Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol. 2012;60:2490-9. [PMID:23103036 ] CrossrefMedlineGoogle Scholar - 38.
Jolly SS ,Mehta SR . Coronary intervention: radial artery access comes of age. Lancet. 2015;385:2437-9. [PMID:25791213 ] CrossrefMedlineGoogle Scholar - 39.
Eikelboom JW ,Mehta SR ,Anand SS ,Xie C ,Fox KA ,Yusuf S . Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774-82. [PMID:16908769 ] CrossrefMedlineGoogle Scholar - 40.
Mehran R ,Pocock S ,Nikolsky E ,Dangas GD ,Clayton T ,Claessen BE ,et al . Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4:654-64. [PMID:21700252 ] MedlineGoogle Scholar - 41.
Kwok CS ,Khan MA ,Rao SV ,Kinnaird T ,Sperrin M ,Buchan I ,et al . Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Interv. 2015;8 4. [PMID:25825007 ] CrossrefMedlineGoogle Scholar - 42.
Jolly SS ,Cairns J ,Yusuf S ,Niemela K ,Steg PG ,Worthley M ,et al ;RIVAL Investigators . Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention. J Am Coll Cardiol. 2014;63:954-63. [PMID:24269362 ] CrossrefMedlineGoogle Scholar - 43.
Moussa ID ,Klein LW ,Shah B ,Mehran R ,Mack MJ ,Brilakis ES ,et al . Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62:1563-70. [PMID:24135581 ] CrossrefMedlineGoogle Scholar - 44.
Mehran R ,Rao SV ,Bhatt DL ,Gibson CM ,Caixeta A ,Eikelboom J ,et al . Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736-47. [PMID:21670242 ] CrossrefMedlineGoogle Scholar - 45.
Ratib K ,Mamas MA ,Anderson SG ,Bhatia G ,Routledge H ,De Belder M ,et al ;British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research . Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United kingdom. JACC Cardiovasc Interv. 2015;8:20-9. [PMID:25616814 ] CrossrefMedlineGoogle Scholar - 46.
Hess CN ,Peterson ED ,Neely ML ,Dai D ,Hillegass WB ,Krucoff MW ,et al . The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry. Circulation. 2014;129:2277-86. [PMID:24756064 ] CrossrefMedlineGoogle Scholar - 47.
Lee MS ,Wolfe M ,Stone GW . Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence. JACC Cardiovasc Interv. 2013;6:1149-52. [PMID:24262614 ] doi:10.1016/j.jcin.2013.08.003 CrossrefMedlineGoogle Scholar
Author, Article and Disclosure Information
From the University of Messina, Messina, and Ferrarotto Hospital, University of Catania, Catania, Italy.
Grant Support: The authors are funded by their academic institutions.
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-1277.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.
Reproducible Research Statement:Study protocol, statistical code, and data set: Available from Dr. Andò (giuseppe.
Corresponding Author: Giuseppe Andò, MD, PhD, Department of Clinical and Experimental Medicine, Section of Cardiology, University of Messina, c/o Azienda Ospedaliera Universitaria Policlinico “Gaetano Martino,” Via Consolare Valeria, 98124 Messina, Italy; e-mail, giuseppe.
Current Author Addresses: Dr. Andò: Department of Clinical and Experimental Medicine, Section of Cardiology, University of Messina, c/o Azienda Ospedaliera Universitaria Policlinico “Gaetano Martino,” Via Consolare Valeria, 98124 Messina, Italy.
Professor Capodanno: Department of General Surgery and Medical-Surgical Specialties, University of Catania, c/o Ospedale Ferrarotto, Via Salvatore Citelli 31, 95124 Catania, Italy.
Author Contributions: Conception and design: G. Andò.
Analysis and interpretation of the data: G. Andò, D. Capodanno.
Drafting of the article: G. Andò, D. Capodanno.
Critical revision of the article for important intellectual content: D. Capodanno.
Final approval of the article: G. Andò, D. Capodanno.
Statistical expertise: G. Andò.
Collection and assembly of data: G. Andò.
This article was published online first at www.annals.org on 10 November 2015.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an AIMCC publication.